Exenatide Wolfram Syndrome Study

Withdrawn single-group interventional study of exenatide in Wolfram syndrome, a genetic syndrome that includes diabetes, optic atrophy, and deafness.

ClinicalTrials.gov verifies a withdrawn Hadassah interventional study of exenatide for Wolfram syndrome. Hearing/deafness is part of the syndrome context, but the study should not be presented as a direct commercial hearing-restoration program.